e-learning
resources
Madrid 2019
Wednesday, 02.10.2019
Exacerbations of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antibiotic choice and repeat prescriptions in infective COPD exacerbations
M. Stolbrink (Liverpool, United Kingdom), L. Bonnett (Liverpool, United Kingdom), J. Blakey (Perth, Australia)
Source:
International Congress 2019 – Exacerbations of airway diseases
Session:
Exacerbations of airway diseases
Session type:
Poster Discussion
Number:
5222
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Stolbrink (Liverpool, United Kingdom), L. Bonnett (Liverpool, United Kingdom), J. Blakey (Perth, Australia). Antibiotic choice and repeat prescriptions in infective COPD exacerbations. 5222
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Less is more? Antibiotic treatment duration for exacerbations of bronchiectasis
Source: Eur Respir J, 58 (6) 2101416; 10.1183/13993003.01416-2021
Year: 2021
COPD: antibiotic strategy in infectious exacerbations
Source: Eur Respir J 2001; 18: Suppl. 33, 137s
Year: 2001
Antibiotics prescriptions increased medical costs for COPD exacerbations.
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019
Antibiotic prescribing in patients with acute bronchitis
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions
Source: Eur Respir J, 53 (5) 1802014; 10.1183/13993003.02014-2018
Year: 2019
Antibiotic prescribing practises of hospital doctors for COPD exacerbations
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901405; 10.1183/13993003.01405-2019
Year: 2019
Is CRP-guided antibiotic treatment a safe way to reduce antibiotic use in severe hospitalised patients with exacerbations of COPD?
Source: Eur Respir J, 54 (4) 1901597; 10.1183/13993003.01597-2019
Year: 2019
The investigation of infectious agents and their antibiotic sensitivities in COPD exacerbations
Source: Eur Respir J 2006; 28: Suppl. 50, 3s
Year: 2006
Does having previous sputum results improve rationalisation of antimicrobial prescribing during acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Antibiotic treatment and prevention of exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 96-106
Year: 2013
Are we over-prescribing antibiotics in acute hospital admissions for exacerbations of COPD?
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Does sputum, biochemical and radiological markers of infection correlate with antibiotic prescribing in acute exacerbations of COPD?
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014
Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Patterns of symptom change measured using the EXACT diary associated with prescription of corticosteroids or antibiotics in COPD exacerbations
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
Association of COPD inhaled medication adherence with hospitalization for acute exacerbation of COPD (AECOPD)
Source: International Congress 2017 – COPD management
Year: 2017
Can we use a biomarker to guide antibiotic treatment in severe COPD exacerbations?
Source: Breathe, 15 (4) 353; 10.1183/20734735.0257-2019
Year: 2019
Antibiotics in COPD exacerbations: practice and evidence
Source: Breathe 2009; 5: 299-301
Year: 2009
Treatment failure of infective exacerbations of COPD
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept